| Medical Life |
1 |
1 |
| COVID-19 |
0 |
0.86 |
| Grant |
0 |
0.86 |
| Otolaryngology |
0 |
0.58 |
| Chronic Obstructive Pulmonary Disease |
0 |
0.53 |
| Pulmonary Arterial Hypertension |
0 |
0.48 |
| Mechanical Ventilation |
0 |
0.45 |
| Asthma |
0 |
0.4 |
| Heart Failure (HF) |
0 |
0.4 |
| Lung |
0 |
0.33 |
| Lung Cancer |
0 |
0.32 |
| Hypertension |
0 |
0.31 |
| Physical Medicine and Rehabilitation (PMR) |
0 |
0.31 |
| Lung Fibrosis |
0 |
0.28 |
| Biliary Disease |
0 |
0.27 |
| Interstitial Lung Disease |
0 |
0.27 |
| Pneumonia |
0 |
0.27 |
| Palliative Care |
0 |
0.22 |
| Skin and Soft Tissue Infection |
0 |
0.22 |
| Sleep Disorders |
0 |
0.21 |
| Severe Asthma |
0 |
0.18 |
| Sepsis |
0 |
0.16 |
| Sleep Apnea |
0 |
0.16 |
| Social Determinants of Health |
0 |
0.15 |
| Acute Respiratory Distress Syndrome |
0 |
0.14 |
| Idiopathic Pulmonary Fibrosis |
0 |
0.14 |
| Biomarker |
0 |
0.13 |
| Cancer |
0 |
0.13 |
| Hospital |
0 |
0.13 |
| Pulmonary Hypertension |
0 |
0.13 |
| Advanced Cancer |
0 |
0.11 |
| California |
0 |
0.1 |
| Cystic Fibrosis |
0 |
0.1 |
| New York |
0 |
0.1 |
| Sarcoidosis |
0 |
0.1 |
| Scleroderma |
0 |
0.1 |
| Sleep |
0 |
0.1 |
| Wound Management |
0 |
0.1 |
| Arrhythmia |
0 |
0.09 |
| Obstructive Sleep Apnea |
0 |
0.09 |
| Canada |
0 |
0.08 |
| Brain Abscess |
0 |
0.06 |
| Abscess |
0 |
0.05 |
| Airway |
0 |
0.05 |
| Depression |
0 |
0.05 |
| Diarrhea |
0 |
0.05 |
| Multiple Sclerosis |
0 |
0.05 |
| Pleural Effusion |
0 |
0.05 |
| Pulmonary Rehabilitation |
0 |
0.05 |
| Tobacco Cessation |
0 |
0.05 |
| Ventilator |
0 |
0.05 |
| Biliary Stent |
0 |
0.04 |
| Coronary Artery Calcification |
0 |
0.04 |
| Endotracheal Intubation |
0 |
0.04 |
| Junior Doctors |
0 |
0.04 |
| Oxidative Stress |
0 |
0.04 |
| Adenocarcinoma |
0 |
0.03 |
| Artery |
0 |
0.03 |
| Arthritis |
0 |
0.03 |
| Bacteria |
0 |
0.03 |
| Bone |
0 |
0.03 |
| Brain |
0 |
0.03 |
| Bronchoscopy |
0 |
0.03 |
| Child |
0 |
0.03 |
| Circadian Rhythm |
0 |
0.03 |
| Comparative Effectiveness |
0 |
0.03 |
| CT Scan |
0 |
0.03 |
| Disease Management |
0 |
0.03 |
| Diversity |
0 |
0.03 |
| Dyspnea |
0 |
0.03 |
| Esophagus |
0 |
0.03 |
| Exercise |
0 |
0.03 |
| Extracorporeal Membrane Oxygenation (ECMO) |
0 |
0.03 |
| Face |
0 |
0.03 |
| Fistula |
0 |
0.03 |
| Health Equity |
0 |
0.03 |
| Hemodynamics |
0 |
0.03 |
| Hypersensitivity Pneumonitis |
0 |
0.03 |
| Inhalers |
0 |
0.03 |
| Injury |
0 |
0.03 |
| Intubation |
0 |
0.03 |
| Jobs |
0 |
0.03 |
| Lymphangioleiomyomatosis |
0 |
0.03 |
| Medical Education |
0 |
0.03 |
| Medical Intensive Care Unit (MICU) |
0 |
0.03 |
| Methacholine Challenge Test |
0 |
0.03 |
| Noninvasive Ventilation |
0 |
0.03 |
| Ohio |
0 |
0.03 |
| Pandemic |
0 |
0.03 |
| Pericardiocentesis |
0 |
0.03 |
| Physiology |
0 |
0.03 |
| Plasma |
0 |
0.03 |
| Polio |
0 |
0.03 |
| Polysomnography |
0 |
0.03 |
| Postoperative |
0 |
0.03 |
| Prognosis |
0 |
0.03 |
| Pulmonary Function Test |
0 |
0.03 |
| Referral |
0 |
0.03 |
| Respiratory Failure |
0 |
0.03 |
| Robotic Surgery |
0 |
0.03 |
| Rural Health |
0 |
0.03 |
| Severe Acute Respiratory Syndrome |
0 |
0.03 |
| Shared Decision-Making |
0 |
0.03 |
| Sinus |
0 |
0.03 |
| Smoking |
0 |
0.03 |
| Stent |
0 |
0.03 |
| Stress |
0 |
0.03 |
| Strongyloidiasis |
0 |
0.03 |
| Suture |
0 |
0.03 |
| Systemic Sclerosis |
0 |
0.03 |
| Texas |
0 |
0.03 |
| Tracheostomy |
0 |
0.03 |
| Transplantation |
0 |
0.03 |
| Tumor |
0 |
0.03 |
| Vitamin |
0 |
0.03 |
| Washington |
0 |
0.03 |